IVERIC bio ( NASDAQ:ISEE – Get Rating ) was downgraded by Morgan Stanley from an 'overweight' rating to an 'equal weight' rating in a note issued to investors on Monday, The Fly reports. ISEE has been the subject of several other reports. Guggenheim lowered IVERIC bio from a 'buy' rating to a 'neutral' rating in a research note on Monday. Wedbush lowered IVERIC bio from an 'outperform' rating to a 'neutral' rating in a research note on Monday. B. Riley upped their price target on IVERIC bio from $17.

https://www.dailypolitical.com/2023/05/01/iveric-bio-nasdaqisee-downgraded-by-morgan-stanley-to-equal-weight.html

#dailypolitical